ID   PPCE_HUMAN              Reviewed;         710 AA.
AC   P48147; Q8N6D4;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Prolyl endopeptidase;
DE            Short=PE;
DE            EC=3.4.21.26;
DE   AltName: Full=Post-proline cleaving enzyme;
GN   Name=PREP; Synonyms=PEP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7959018; DOI=10.1016/0378-1119(94)90177-5;
RA   Vanhoof G., Goossens F., Hendriks L., De Meester I., Hendriks D.,
RA   Vriend G., van Broeckhoven C., Scharpe S.;
RT   "Cloning and sequence analysis of the gene encoding human lymphocyte
RT   prolyl endopeptidase.";
RL   Gene 149:363-366(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-706.
RX   PubMed=8089089; DOI=10.1093/oxfordjournals.jbchem.a124402;
RA   Shirasawa Y., Osawa T., Hirashima A.;
RT   "Molecular cloning and characterization of prolyl endopeptidase from
RT   human T cells.";
RL   J. Biochem. 115:724-729(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tarrago T., Giralt E.;
RT   "cDNA cloning and recombinant expression of human brain prolyl
RT   oligopeptidase.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 136-149, SUBUNIT, AND CHARACTERIZATION.
RC   TISSUE=Lymphocyte;
RX   PubMed=7588785; DOI=10.1111/j.1432-1033.1995.432_2.x;
RA   Goossens F., De Meester I., Vanhoof G., Hendriks D., Vriend G.,
RA   Scharpe S.;
RT   "The purification, characterization and analysis of primary and
RT   secondary-structure of prolyl oligopeptidase from human lymphocytes.
RT   Evidence that the enzyme belongs to the alpha/beta hydrolase fold
RT   family.";
RL   Eur. J. Biochem. 233:432-441(1995).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.56 ANGSTROMS) OF 2-710 IN COMPLEX WITH
RP   INHIBITOR.
RX   PubMed=18606544; DOI=10.1016/j.bmcl.2008.06.067;
RA   Haffner C.D., Diaz C.J., Miller A.B., Reid R.A., Madauss K.P.,
RA   Hassell A., Hanlon M.H., Porter D.J., Becherer J.D., Carter L.H.;
RT   "Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors
RT   of prolyl oligopeptidase (POP).";
RL   Bioorg. Med. Chem. Lett. 18:4360-4363(2008).
CC   -!- FUNCTION: Cleaves peptide bonds on the C-terminal side of prolyl
CC       residues within peptides that are up to approximately 30 amino
CC       acids long.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of Pro-|-Xaa >> Ala-|-Xaa in
CC       oligopeptides.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:18606544,
CC       ECO:0000269|PubMed:7588785}.
CC   -!- INTERACTION:
CC       P04406:GAPDH; NbExp=5; IntAct=EBI-1049962, EBI-354056;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- SIMILARITY: Belongs to the peptidase S9A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X74496; CAA52605.1; -; mRNA.
DR   EMBL; D21102; BAA04661.1; -; mRNA.
DR   EMBL; AY660966; AAV70495.1; -; mRNA.
DR   EMBL; AL590871; CAH72545.1; -; Genomic_DNA.
DR   EMBL; AL133406; CAH72545.1; JOINED; Genomic_DNA.
DR   EMBL; AL139191; CAH72545.1; JOINED; Genomic_DNA.
DR   EMBL; AL139191; CAI21416.1; -; Genomic_DNA.
DR   EMBL; AL133406; CAI21416.1; JOINED; Genomic_DNA.
DR   EMBL; AL590871; CAI21416.1; JOINED; Genomic_DNA.
DR   EMBL; AL133406; CAI42689.1; -; Genomic_DNA.
DR   EMBL; AL139191; CAI42689.1; JOINED; Genomic_DNA.
DR   EMBL; AL590871; CAI42689.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48426.1; -; Genomic_DNA.
DR   EMBL; BC030636; AAH30636.1; -; mRNA.
DR   CCDS; CCDS5053.1; -.
DR   PIR; I38134; I38134.
DR   PIR; JC2257; JC2257.
DR   RefSeq; NP_002717.3; NM_002726.4.
DR   UniGene; Hs.436564; -.
DR   PDB; 3DDU; X-ray; 1.56 A; A=2-710.
DR   PDBsum; 3DDU; -.
DR   ProteinModelPortal; P48147; -.
DR   SMR; P48147; -.
DR   BioGrid; 111541; 26.
DR   IntAct; P48147; 2.
DR   MINT; MINT-5004282; -.
DR   STRING; 9606.ENSP00000358106; -.
DR   BindingDB; P48147; -.
DR   ChEMBL; CHEMBL3202; -.
DR   DrugBank; DB01684; 1-Hydroxy-1-Thio-Glycerol.
DR   DrugBank; DB08738; 1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one.
DR   DrugBank; DB03864; Monothioglycerol.
DR   DrugBank; DB00107; Oxytocin.
DR   DrugBank; DB03382; S-Oxy Cysteine.
DR   DrugBank; DB03535; Z-Pro-Prolinal.
DR   GuidetoPHARMACOLOGY; 2395; -.
DR   ESTHER; human-PREP; S9N_PPCE_Peptidase_S9.
DR   MEROPS; S09.001; -.
DR   iPTMnet; P48147; -.
DR   PhosphoSitePlus; P48147; -.
DR   SwissPalm; P48147; -.
DR   BioMuta; PREP; -.
DR   DMDM; 215273868; -.
DR   EPD; P48147; -.
DR   MaxQB; P48147; -.
DR   PaxDb; P48147; -.
DR   PeptideAtlas; P48147; -.
DR   PRIDE; P48147; -.
DR   DNASU; 5550; -.
DR   Ensembl; ENST00000369110; ENSP00000358106; ENSG00000085377.
DR   GeneID; 5550; -.
DR   KEGG; hsa:5550; -.
DR   UCSC; uc003prc.4; human.
DR   CTD; 5550; -.
DR   DisGeNET; 5550; -.
DR   GeneCards; PREP; -.
DR   HGNC; HGNC:9358; PREP.
DR   HPA; CAB025414; -.
DR   HPA; HPA031388; -.
DR   HPA; HPA031389; -.
DR   HPA; HPA031390; -.
DR   MalaCards; PREP; -.
DR   MIM; 600400; gene.
DR   neXtProt; NX_P48147; -.
DR   OpenTargets; ENSG00000085377; -.
DR   PharmGKB; PA33730; -.
DR   eggNOG; KOG2237; Eukaryota.
DR   eggNOG; COG1505; LUCA.
DR   GeneTree; ENSGT00530000063426; -.
DR   HOGENOM; HOG000238967; -.
DR   HOVERGEN; HBG007251; -.
DR   InParanoid; P48147; -.
DR   KO; K01322; -.
DR   OMA; VQDYHGH; -.
DR   OrthoDB; EOG091G023D; -.
DR   PhylomeDB; P48147; -.
DR   TreeFam; TF300655; -.
DR   BRENDA; 3.4.21.26; 2681.
DR   EvolutionaryTrace; P48147; -.
DR   GeneWiki; Prolyl_endopeptidase; -.
DR   GenomeRNAi; 5550; -.
DR   PMAP-CutDB; Q8N6D4; -.
DR   PRO; PR:P48147; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000085377; -.
DR   CleanEx; HS_PREP; -.
DR   ExpressionAtlas; P48147; baseline and differential.
DR   Genevisible; P48147; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro.
DR   GO; GO:0008236; F:serine-type peptidase activity; TAS:ProtInc.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002471; Pept_S9_AS.
DR   InterPro; IPR023302; Pept_S9A_N.
DR   InterPro; IPR001375; Peptidase_S9.
DR   InterPro; IPR002470; Peptidase_S9A.
DR   Pfam; PF00326; Peptidase_S9; 1.
DR   Pfam; PF02897; Peptidase_S9_N; 1.
DR   PRINTS; PR00862; PROLIGOPTASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00708; PRO_ENDOPEP_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Polymorphism; Protease;
KW   Reference proteome; Serine protease.
FT   CHAIN         1    710       Prolyl endopeptidase.
FT                                /FTId=PRO_0000122401.
FT   ACT_SITE    554    554       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10084}.
FT   ACT_SITE    641    641       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10084}.
FT   ACT_SITE    680    680       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10084}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     157    157       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     351    351       L -> V (in dbSNP:rs12192054).
FT                                /FTId=VAR_047790.
FT   VARIANT     706    706       V -> I (in dbSNP:rs1051484).
FT                                {ECO:0000269|PubMed:8089089}.
FT                                /FTId=VAR_047791.
FT   CONFLICT      4      4       L -> F (in Ref. 1; CAA52605 and 2;
FT                                BAA04661). {ECO:0000305}.
FT   CONFLICT     16     16       V -> I (in Ref. 2; BAA04661).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       R -> C (in Ref. 2; BAA04661).
FT                                {ECO:0000305}.
FT   CONFLICT    298    298       T -> A (in Ref. 2; BAA04661).
FT                                {ECO:0000305}.
FT   CONFLICT    319    319       R -> W (in Ref. 1; CAA52605).
FT                                {ECO:0000305}.
FT   CONFLICT    440    440       I -> L (in Ref. 2; BAA04661).
FT                                {ECO:0000305}.
FT   CONFLICT    459    459       G -> S (in Ref. 2; BAA04661).
FT                                {ECO:0000305}.
FT   STRAND       16     19       {ECO:0000244|PDB:3DDU}.
FT   STRAND       22     25       {ECO:0000244|PDB:3DDU}.
FT   HELIX        29     32       {ECO:0000244|PDB:3DDU}.
FT   HELIX        37     55       {ECO:0000244|PDB:3DDU}.
FT   HELIX        59     70       {ECO:0000244|PDB:3DDU}.
FT   STRAND       80     82       {ECO:0000244|PDB:3DDU}.
FT   STRAND       85     91       {ECO:0000244|PDB:3DDU}.
FT   STRAND       99    105       {ECO:0000244|PDB:3DDU}.
FT   STRAND      111    114       {ECO:0000244|PDB:3DDU}.
FT   HELIX       116    119       {ECO:0000244|PDB:3DDU}.
FT   STRAND      121    123       {ECO:0000244|PDB:3DDU}.
FT   STRAND      125    132       {ECO:0000244|PDB:3DDU}.
FT   STRAND      136    145       {ECO:0000244|PDB:3DDU}.
FT   STRAND      151    157       {ECO:0000244|PDB:3DDU}.
FT   TURN        158    161       {ECO:0000244|PDB:3DDU}.
FT   STRAND      162    171       {ECO:0000244|PDB:3DDU}.
FT   STRAND      176    178       {ECO:0000244|PDB:3DDU}.
FT   STRAND      182    189       {ECO:0000244|PDB:3DDU}.
FT   STRAND      198    200       {ECO:0000244|PDB:3DDU}.
FT   STRAND      209    214       {ECO:0000244|PDB:3DDU}.
FT   HELIX       219    221       {ECO:0000244|PDB:3DDU}.
FT   STRAND      223    226       {ECO:0000244|PDB:3DDU}.
FT   STRAND      235    240       {ECO:0000244|PDB:3DDU}.
FT   STRAND      246    257       {ECO:0000244|PDB:3DDU}.
FT   STRAND      260    265       {ECO:0000244|PDB:3DDU}.
FT   HELIX       266    268       {ECO:0000244|PDB:3DDU}.
FT   STRAND      270    273       {ECO:0000244|PDB:3DDU}.
FT   STRAND      280    283       {ECO:0000244|PDB:3DDU}.
FT   STRAND      285    288       {ECO:0000244|PDB:3DDU}.
FT   STRAND      290    296       {ECO:0000244|PDB:3DDU}.
FT   STRAND      299    304       {ECO:0000244|PDB:3DDU}.
FT   STRAND      312    317       {ECO:0000244|PDB:3DDU}.
FT   HELIX       323    325       {ECO:0000244|PDB:3DDU}.
FT   STRAND      327    330       {ECO:0000244|PDB:3DDU}.
FT   STRAND      337    344       {ECO:0000244|PDB:3DDU}.
FT   TURN        345    347       {ECO:0000244|PDB:3DDU}.
FT   STRAND      348    355       {ECO:0000244|PDB:3DDU}.
FT   STRAND      358    365       {ECO:0000244|PDB:3DDU}.
FT   TURN        366    368       {ECO:0000244|PDB:3DDU}.
FT   STRAND      371    375       {ECO:0000244|PDB:3DDU}.
FT   STRAND      379    386       {ECO:0000244|PDB:3DDU}.
FT   STRAND      392    399       {ECO:0000244|PDB:3DDU}.
FT   STRAND      401    403       {ECO:0000244|PDB:3DDU}.
FT   STRAND      406    411       {ECO:0000244|PDB:3DDU}.
FT   STRAND      414    416       {ECO:0000244|PDB:3DDU}.
FT   STRAND      420    423       {ECO:0000244|PDB:3DDU}.
FT   HELIX       432    434       {ECO:0000244|PDB:3DDU}.
FT   STRAND      435    443       {ECO:0000244|PDB:3DDU}.
FT   STRAND      449    457       {ECO:0000244|PDB:3DDU}.
FT   STRAND      468    471       {ECO:0000244|PDB:3DDU}.
FT   HELIX       486    495       {ECO:0000244|PDB:3DDU}.
FT   STRAND      498    502       {ECO:0000244|PDB:3DDU}.
FT   HELIX       511    516       {ECO:0000244|PDB:3DDU}.
FT   HELIX       520    523       {ECO:0000244|PDB:3DDU}.
FT   HELIX       524    539       {ECO:0000244|PDB:3DDU}.
FT   HELIX       545    547       {ECO:0000244|PDB:3DDU}.
FT   STRAND      548    553       {ECO:0000244|PDB:3DDU}.
FT   HELIX       555    566       {ECO:0000244|PDB:3DDU}.
FT   HELIX       568    570       {ECO:0000244|PDB:3DDU}.
FT   STRAND      572    578       {ECO:0000244|PDB:3DDU}.
FT   TURN        583    585       {ECO:0000244|PDB:3DDU}.
FT   HELIX       586    588       {ECO:0000244|PDB:3DDU}.
FT   HELIX       592    595       {ECO:0000244|PDB:3DDU}.
FT   HELIX       596    599       {ECO:0000244|PDB:3DDU}.
FT   HELIX       605    614       {ECO:0000244|PDB:3DDU}.
FT   HELIX       616    618       {ECO:0000244|PDB:3DDU}.
FT   STRAND      632    638       {ECO:0000244|PDB:3DDU}.
FT   HELIX       647    659       {ECO:0000244|PDB:3DDU}.
FT   TURN        660    662       {ECO:0000244|PDB:3DDU}.
FT   STRAND      670    677       {ECO:0000244|PDB:3DDU}.
FT   HELIX       686    704       {ECO:0000244|PDB:3DDU}.
SQ   SEQUENCE   710 AA;  80700 MW;  139072B990820B90 CRC64;
     MLSLQYPDVY RDETAVQDYH GHKICDPYAW LEDPDSEQTK AFVEAQNKIT VPFLEQCPIR
     GLYKERMTEL YDYPKYSCHF KKGKRYFYFY NTGLQNQRVL YVQDSLEGEA RVFLDPNILS
     DDGTVALRGY AFSEDGEYFA YGLSASGSDW VTIKFMKVDG AKELPDVLER VKFSCMAWTH
     DGKGMFYNSY PQQDGKSDGT ETSTNLHQKL YYHVLGTDQS EDILCAEFPD EPKWMGGAEL
     SDDGRYVLLS IREGCDPVNR LWYCDLQQES SGIAGILKWV KLIDNFEGEY DYVTNEGTVF
     TFKTNRQSPN YRVINIDFRD PEESKWKVLV PEHEKDVLEW IACVRSNFLV LCYLHDVKNI
     LQLHDLTTGA LLKTFPLDVG SIVGYSGQKK DTEIFYQFTS FLSPGIIYHC DLTKEELEPR
     VFREVTVKGI DASDYQTVQI FYPSKDGTKI PMFIVHKKGI KLDGSHPAFL YGYGGFNISI
     TPNYSVSRLI FVRHMGGILA VANIRGGGEY GETWHKGGIL ANKQNCFDDF QCAAEYLIKE
     GYTSPKRLTI NGGSNGGLLV AACANQRPDL FGCVIAQVGV MDMLKFHKYT IGHAWTTDYG
     CSDSKQHFEW LVKYSPLHNV KLPEADDIQY PSMLLLTADH DDRVVPLHSL KFIATLQYIV
     GRSRKQSNPL LIHVDTKAGH GAGKPTAKVI EEVSDMFAFI ARCLNVDWIP
//
